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The present study was carried out to evaluate the antidiabetic activity of Vinca rosea methanolic whole plant extracts in alloxan
induced diabetic rats for 14 days. The methanolic whole plant extract at high dose (500mg/kg) exhibited signiﬁcant anti-
hyperglycemic activity than whole plant extract at low dose (300mg/kg) in diabetic rats. The methanolic extracts also showed
improvement in parameters like body weight and lipid proﬁle as well as regeneration of β-cells of pancreas in diabetic rats.
Histopathological studies reinforce the healing of pancreas, by methanolic Vinca rosea extracts, as a possible mechanism of their
antidiabetic activity.
1.Introduction
Diabetes mellitus is one of the common metabolic disorders
with micro-and macrovascular complications that results in
signiﬁcant morbidity and mortality. It is considered as one
of the ﬁve leading causes of death in the world [1, 2]. In
modern medicine no satisfactory eﬀective therapy is still
available to cure diabetes mellitus [3]. There is increasing
demand by patients to use natural products with antidiabetic
a c t i v i t yd u et os i d ee ﬀects associated with the use of insulin
a n do r a lh y p o g l y c e m i ca g e n t s[ 4–6]. There are numerous
traditional medicinal plants reported to have hypoglycemic
properties such as Allium sativum (Garlic), Azadirachta
indica (Neem), Vinca rosea (Nayantara), Trigonella foenum
(Fenugreek), Momordica charantia (Bitter ground), Ocimum
santum (Tulsi). Many of these are less eﬀective in lowering
glucose levels in severe diabetes.
Vinca rosea (C. roseus) Linn. (Apocynaceae) is an herba-
ceous subshrub also known as Madagascar periwinkle, Vinca
rosea,o rLchnera rosea worldwide. It is cultivated mainly
for its alkaloids, which are having anticancer activities [7].
The two classes of active compounds in Vinca are alkaloids
and tannins. Catharanthus roseus produces more than 100
monoterpenoids indole alkaloids (TIA) in diﬀerent organs
[8].Theleavesandstemsarethesourcesofdimericalkaloids,
vinacristine and vinblastine that are indispensable cancer
drugs, while roots have antihypertensive, ajmalicine and
serpentine [9]. The leaves are used traditionally in various
regions of the world including India, West Indies as well
as Nigeria to control diabetes [10]. The leaves have been
known to contain 150 useful alkaloids among other pharma-
cologically active compounds. Signiﬁcant antihyperglycemic
and hypotensive activity of the leaf extracts (hydroalcoholic
or dichloromethane-methanol) have been reported in lab-
oratory animals [11]. Fresh leaf juice of C. roseus has been
reported to reduce blood glucose in normal and alloxan
diabetic rabbits [12]. Leaves and twigs of Catharanthus
roseus have been reported to have hypoglycaemic activity in
streptozotocin induced diabetic rats [13]. In this study the
prolonged eﬀect (up to 14 day) of the methanolic extracts of2 International Journal of Endocrinology
wholeplantofVinca rosea infastingbloodglucose(FBG)and
biochemicalparameterssuchasserumtotalcholesterol(TC),
LDL, HDL, creatinine, urea, and alkaline phosphatase were
studied in alloxan induced diabetic rats. Hence on the above
fact no study has been carried out on methanolic extracts of
whole plant of Vinca rosea in alloxan induced diabetic rats.
Thus the present study is an attempt to test the antidiabetic
activity of whole plant of the Vinca rosea.
2.MaterialsandMethods
2.1. Plant Material. The basic plant material of Vinca rosea
Linn whole plant used for the investigation was obtain from
Mount Opera Garden, Near Ramoji Film City, Nalgonda
Dist, Andhra Pradesh, India. The plant can be identiﬁed
authenticated by department of Botany research oﬃce
(Botanist) Anwar-ul-loom College of Pharmacy, Hyderabad.
2.2. Alcoholic Extraction. The whole plants were collected
and shadow dried. The shade-dried whole plants were
subjected to pulverization to get coarse powder. The coarsely
powder whole plant (1kg) of Vinca rosea Linn was used for
extraction with methanol in soxlate apparatus. The extract
was evaporated to dryness under vacuum and dried in
vacuum desiccator (15.5% w/w).
2.3. Animals. Wistar albino rats (8–10 weeks) of both sexes
were obtained from the animal house of Nizam Institute Of
Pharmacy,Deshmukhi,RamojiFilmCity,Hyderabad.Before
and during the experiment, rats were fed with standard
diet (Gold Moher, Lipton India Ltd). After randomization
into various groups and before initiation of experiment,
the rats were acclimatized for a period of 7 days under
standard environmental conditions of temperature, relative
humidity, and dark/light cycle. Animals described as fasting
were deprived of food and water for 16 hours ad libitum.
2.4. Oral Glucose Tolerance Test. Rats were divided into six
groups containing six animals in each group. All animals
fasted before treatment. Group I was kept as vehicle control
which received 5% Tween 80 p.o., group II received glucose
only, group III received methanolic extract300 mg/kg, group
IV received methanolic extract 500 mg/kg and group V and
VI received only extracts (300mg/kg and 500mg/kg) only
in a vehicle, respectively.The rats of group III and IV were
loaded with glucose (3g/kg, p.o.) 30 minutes after drug
administration. Blood samples were collected from punctur-
ing the retro orbital sinus just prior to drug administration,
and 30, 90, 150 minutes after loading glucose. Serum glucose
level was measured immediately by using glucose estimation
kit (Span Diagnostic Pvt. Ltd. Surat, India).
2.5. Acute Oral Toxicity Studies. Vinca rosea at the dose range
of 100mg–2000mg/kg were administered orally to diﬀerent
g r o u po fr a t sc o m p r i s e do ft e nr a t si ne a c hg r o u p .M o r t a l i t y
was observed after 72 hours. Acute toxicity was determined
according to the method of Litchﬁeld and Wilcoxon [14].
2.6. Experimental Design. Five groups of rats, six in each
received the following treatment schedule.
Group I: Normal control (saline).
Group II: Alloxan treated control (150mg/kg.ip).
Group III: Alloxan (150mg/kg.ip) + Vinca rosea.
Whole plants extract (300mg/kg, p.o),
Group IV: Alloxan (150mg/kg.ip) + Vinca rosea.
Whole plants extract (500mg/kg, p.o),
Group V: Alloxan (150mg/kg.ip) + Standard drug,
Glibenclamide (5mg/kg, p.o).
Whole plant extracts and standard drug glibenclamide
(5mg/kg) and saline were administered with the help of
feeding cannula. Group I serve as normal control, which
received saline for 14 days. Group II to Group V are
diabeticcontrolrats.GroupIIItoGroupV(whichpreviously
received alloxan) are given a ﬁxed dose whole plants
extract (300mg/kg, p.o), (500mg/kg, p.o) and standard drug
glibenclamide (5mg/kg) for 14 consecutive days.
2.7.InductionofDiabetesinExperimentalAnimals. Ratswere
made diabetic by a single intraperitoneal injection of alloxan
monohydrate (150mg/kg) [15]. Alloxan was ﬁrst weighed
individually for each animal according to the body weight
and then solubilized with 0.2ml saline (154mM NaCl) just
prior to injection. Two days after alloxan injection, rats with
plasma glucose levels of >140mg/dl were included in the
study. Treatment with plant extracts was started 48 h after
alloxan injection.
2.8. Collection of Blood Sample and Blood Glucose Determina-
tion. Blood samples were drawn from tail tip of rat at weekly
intervals till the end of study (i.e., 2 weeks). Fasting blood
glucose estimation and body weight measurement were done
onday1,7,and14ofthestudy.Bloodglucoseestimationcan
be done by one touch electronic glucometer using glucose
test strips.
On day 14, blood was collected from retro-orbital plexus
under mild ether anesthesia from overnight fasted rats and
fasting blood sugar was estimated [16]. Serum was separated
and analyzed for serum cholesterol [17], serum triglycerides
by enzymatic DHBS colorimetric method [18], serum HDL
[19], serum LDL [20], serum creatinine [21], serum urea
[22] and serum alkaline phosphatase hydrolyzed phenol
amino antipyrine method [23] was estimated. The whole
pancreas from each animal was removed after sacriﬁcing the
animal and was collected in 10% formaline solution, and
immediately processed by the paraﬃn technique. Sections of
5μ thickness were cut and stained by haematoxylin and eosin
(H & E) for histological examination.
2.9. Statistical Analysis. All the values of body weight, fasting
blood sugar, and biochemical estimations were expressed as
mean±standard error of mean (S.E.M.) and analyzed for
ANOVA and post hoc Dunnet’s t-test. Diﬀerences between
groups were considered signiﬁcant at P < .01 levels.International Journal of Endocrinology 3
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Figure 1: Histopathological studies of pancreas: Group I (Control), Group II (Alloxan 150mg/kg), Group III (Alloxan + Whole Plant
300mg/kg), Group IV (Alloxan + Whole Plant 500mg/kg) and Group V (Alloxan + glibenclamide (5mg/kg).
3. Results
3.1. Glucose Tolerance. The eﬀects of extracts of Vinca rosea
(500mg/kg and 300mg/kg) on glucose tolerance test are
shown in Figure 2. The supplementation of Vinca rosea
improved the glucose tolerance in the fasted normal rats.
After that serum glucose level was lowered signiﬁcantly
(P < .05) at 90 minutes and varied signiﬁcantly (P < .01)
lowered at 150 minutes. Extract also showed signiﬁcant
hypoglycemic eﬀect after 90 minutes of treatment.
3.2. Experimental Results. The acute oral toxicity study of
Vinca rosea showed no mortality upto 2000mg/kg. The
anti-hyperglycemic eﬀect of the extracts on the fasting
b l o o ds u g a rl e v e l so fd i a b e t i cr a t si ss h o w ni nFigure 3.
Administration of alloxan (150mg/kg, i.p.) lead to 1.5-
fold elevation of fasting blood glucose levels, which was
maintained over a period of 2 weeks. Two weeks of daily
treatment of various extract of Vinca rosea lead to a dose-
dependent fall in blood sugar levels by 25%–50%. Eﬀect
was maximum till 14 days of treatment. Vehicle control
animals were found to be slightly increased in their body
weight but diabetic rats showed signiﬁcant reduction in
body weight during 14 days (Figure 4). Alloxan caused body
weight reduction, which is reversed by whole plant extract
at high dose (500mg/kg) is more eﬀectively than whole
plant extract at low dose (300mg/kg) after 14 days of treat-
ment (Figure 4). Alloxan treatment will increase the serum
enzymes levels such as cholesterol,LDL, creatinine, urea
and alkaline phosphatase and decrease the HDL level, but
glibenclamide (5mg/kg) and whole plant extracts of Vinca
rosea reversed the above alloxan induce changes (Table 1 ).
Histopathological studies (Figure 1) showed normal acini
and normal cellular population in the islets of Langerhans
in pancreas of control rats (Group I). Extensive damage to
the islets of Langerhans and reduced dimensions of islets
(Group II), restoration of normal cellular population size of
islets with hyperplasia by glibenclamide (Group V) were also
shown. The partial restoration of normal cellular population
and enlarged size of β-cells with hyperplasia were shown by
methanolic extracts (Figure 1. Group III & Group IV).
4. Discussion
In light of the results, our study indicates that methanolic
extracts of Vinca rosea have good antidiabetic activity.
Alcoholic extracts of Vinca rosea exhibited signiﬁcant anti-
hyperglycemic activities in alloxan-induced hyperglycemic
rats without signiﬁcant change in body weight; they can also
improve the condition of Diabetic mellitus as indicated by
parameters like body weight & lipid proﬁle along with serum
creatinine, serum urea and serum alkaline phosphatase.4 International Journal of Endocrinology
Table 1: Eﬀect of various groups of Vinca rosea on serum proﬁle in alloxan (150mg/kg, i.p.) induced diabetic albino rats after 14 days of
treatment.
Groups Colesterol
(mg/dl) H.D.L(mg/dl) L.D.L(mg/dl) Creatinine(mg/dl) Urea(mg/dl)
Alkaline
Phosphatase
(mg/dl)
Normal control 145.36 ± 3.2 36.83 ± 2.5 91.32 ± 1.2 0.54 ± 0.3 31.83 ± 2.2 120 ± 3.2
Diabetic control 271.16 ± 10.5 30.00 ± 1.9 189 ± 12.4 2.4 ± 0.1 62.6 ± 1.8 276.00 ± 3.6
Alloxan + Whole
plant extract
(300mg/kg,p.o)
184.32 ± 2.5∗ 34.22 ± 4.3∗ 120.27 ± 1.4∗ 0.98 ± 0.3∗ 43.32±3.8∗ 146.35 ± 4.9∗
Alloxan + Whole
plant extract
(500mg/kg,p.o)
158.46 ± 5.6∗ 36.63 ± 2.1∗ 93.65 ± 3.6∗ 0.60 ± 0.2∗ 32.33±2.0∗ 135.55 ± 4.9∗
Alloxan +
glibenclamide
(5mg/kg)
145.42 ± 5.3∗ 36.73 ± 1.5∗ 92.35 ± 3.1∗ 0.58 ± 0.1∗ 31.24±4.0∗ 130.75 ± 2.9∗
Values are given as mean ± SEM for groups of six animals each ∗P < .01 (Dunnet t-test). Diabetic control was compared with the vehicle control and extract
treated groups were compared with the diabetic control.
0
20
40
60
80
100
120
140
G
l
u
c
o
s
e
l
e
v
e
l
0 30 90 150
Time (min)
Control group
Glucose treated group
Extract (300mg/kg)+ glucose
Extract (500mg/kg)+ glucose
Extract (300mg/kg)
Extract (500mg/kg)
Figure 2: Eﬀect of methanolic extract of Vinca rosea on glucose
tolerance test.
The renewal of β cells in diabetes have been studied in
several animal models. The total β cell mass reﬂects the
balance between the renewal and loss of these cells. It was
also suggested that regeneration of islet ß cells following
destruction by alloxan may be the primary cause of the
recovery of alloxan-injected guinea pigs from the eﬀects of
the drug [24]. Vinca rosea whole plant alcoholic extracts
has been shown to act by β cell regeneration. Similar eﬀects
in streptozotocin-treated diabetic animals were reported by
pancreas tonic [25], ephedrine [26], and Gymnema sylvestre
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Figure 3: Eﬀect of diﬀerent groups on blood glucose (mg/dl) level
in alloxan-induced diabetic.
leaf extracts [27]. In our studies, the damage of pancreas
in alloxan-treated diabetic control rats (Figure 1 Group
II) and regeneration of β cells by glibenclamide (Figure 1
Group V) was observed. It is found that methanolic whole
plant extract at high dose (500mg/kg) is more eﬀective
than whole plant extract at low dose (300mg/kg) after 14
days of treatment. Hence the above discussion revels that
methanolic whole plant extract at high dose (500mg/kg) is
more eﬀective and shows similar curative eﬀect as standard
that is, glibenclamide (5mg/kg). This could be due to the
possibility that some β-cells are still surviving to act upon
by Vinca rosea extract to exert its insulin releasing eﬀect.
Histopathological studies reinforce the healing of pancreas,
by Vinca rosea extracts, as a possible mechanism of their
antidiabetic activity.International Journal of Endocrinology 5
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Figure 4: The eﬀect of 2-week treatment with various extracts
of Vinca rosea on body weight (g) after alloxan (150mg/kg i.p.)
induced diabetes in rats.
5. Conclusions
The whole plant extracts did not show a consistent eﬀect
on normal blood sugar levels but it eﬀectively reversed
the alloxan-induced changes in the blood sugar level and
the beta-cell population in the pancreas. It also showed
ap r o t e c t i v ee ﬀect when it was given prior to alloxan
administration. The action of whole plant extracts on the
pancreatic beta-cells and absence of acute toxicity may oﬀer
a new hope to the diabetics in future.
From the above discussion it conclude that alcoholic
whole plant extracts of Vinca rosea at high dose (500mg/kg)
exhibited signiﬁcant antihyperglycemic activity than whole
plant extract at low dose (300mg/kg) in alloxan-induced
diabetic rats. These extracts also showed improvement in
parameters like body weight and lipid proﬁle as well as
regeneration of β c e l l so fp a n c r e a sa n ds om i g h tb eo fv a l u e
in diabetes treatment. Further investigation is in necessary
to determine the exact phytoconstituents (s) responsible for
antidiabetic eﬀect.
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